Torrent Pharmaceuticals Limited

Yield per half year: +8.26%
Dividend yield: 0.9135%
Sector: Healthcare

Torrent Pharmaceuticals Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
1/10
63.69 101.26 -37.11% 51.36 +24.01%
P/S 10.57 13.09 -19.24%
P/BV 16.03 6.58 143.83%
P/FCF 61.65 31.47 95.89%
Ev/Ebitda 30.43 16.9 80.06%
Ev/S 9.71 10.1 -3.86%
Ev/FCF 56.67 32.61 73.77%
E/P 0.0157 0.0314 -50.01%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
9/10
31.92 -6.64 -580.55% 29.9 +6.74%
ROE 25.17 15.84 58.92%
ROA 12.75 7.66 66.4%
ROIC 25.18 15.5 62.43%
ROS 16.59 -15.15 -209.51%
ROCE 38.55 17.75 117.24%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
9/10
0.8711 1.13 -23.17% 1.56 -44.28%
Nеt Debt/Ebitda 0.7136 0.3504 103.66%
Debt/Ratio 0.2136 0.1597 33.74%
Debt/Equity 0.9747 0.6505 49.83%
Debt/Net Income 1.68 28.22 -94.06%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
2.28/10
0.9135 0.6029 51.51% 0.9865 -7.4%
Number of years of dividend growth 0 1.26 -100%
DSI 0.9286 0.8357 11.11%
Average dividend growth -18.76 -68.14 -72.47%
Average percentage for 5 years 0.9865 5.8 -83%
Average percentage for payments 41.83 24.02 74.13%
Difference from average difference in sector 0.3106

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
6/10
46.03 206.21 -77.68%
Growth impulse Ebitda in 5 years 45.57 230.99 -80.27%
Growth impulse Net Income in 5 years 52.65 217.1 -75.75%
Growth impulse FCF in 5 years 17.81 151.51 -88.25%
Growth impulse EPS in 5 years -23.61 228.35 -110.34%
IP Score
5.44/10

Similar companies

Divi's Laboratories Limited

Dr. Reddy's Laboratories Limited

Sun Pharmaceutical Industries Limited

Cipla Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription